Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Neuropathic pain reduced with transdermal fentanyl

Nov. 26, 2007

Recent patents describe novel agents for psychiatric disorders

Nov. 23, 2007

Risperidone beneficial in refractory major depressive disorder

Nov. 23, 2007

Glycine, D-cycloserine ineffective in CONSIST schizophrenia trial

Nov. 23, 2007

Array BioPharma initiates phase II trial of ARRY-797 for dental pain

Nov. 22, 2007

Biogen Idec and Neurimmune enter agreement for antibodies for Alzheimer's disease

Nov. 22, 2007

First-in-human study assesses effects of SB-705498 on pain, hyperalgesia

Nov. 22, 2007

Amarin completes data review of phase III TREND-HD clinical trial of Miraxion

Nov. 22, 2007

Recent patents disclose novel analgesic agents

Nov. 22, 2007

Abilify receives FDA approval for adjunctive treatment of MDD

Nov. 21, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...